Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

RVTY

Revvity Inc

Dec 12 • 10:46AM ET

116.16

Dollar change -0.48
Percentage change -0.41	%

Healthcare • Diagnostics & Research • USA • NYSE

Peers: TMO DHR A MTD BIO WAT BRKR ILMN

| Held by: VTI VOO VO SPY IVV RSP VTV XLV VOE TCAF

Scroll to Statements

Index	S&P 500	P/E	47.20	EPS (ttm)	2.46	Insider Own	0.38%	Shs Outstand	122.09M	Perf Week	0.93%
Market Cap	14.14B	Forward P/E	22.78	EPS next Y	5.10	Insider Trans	-5.93%	Shs Float	121.23M	Perf Month	-3.48%
Income	303.52M	PEG	6.01	EPS next Q	1.37	Inst Own	90.98%	Short Float	3.56%	Perf Quarter	-4.81%
Sales	2.72B	P/S	5.19	EPS this Y	4.26%	Inst Trans	-0.27%	Short Ratio	5.15	Perf Half Y	4.91%
Book/sh	64.88	P/B	1.79	EPS next Y	5.16%	ROA	1.97%	Short Interest	4.31M	Perf Year	29.85%
Cash/sh	10.10	P/C	11.50	EPS next 5Y	7.85%	ROE	3.31%	52W Range	88.90 - 129.50	Perf YTD	6.27%
Dividend Est.	0.28 (0.24%)	P/FCF	25.05	EPS past 5Y	-	ROI	2.70%	52W High	-10.30%	Beta	1.03
Dividend TTM	0.28 (0.24%)	Quick Ratio	2.97	Sales past 5Y	1.15%	Gross Margin	52.15%	52W Low	30.66%	ATR (14)	3.01
Dividend Ex-Date	Jan 17, 2025	Current Ratio	3.56	EPS Y/Y TTM	-58.67%	Oper. Margin	13.87%	RSI (14)	48.35	Volatility	2.45% 2.64%
Employees	11500	Debt/Eq	0.42	Sales Y/Y TTM	-2.66%	Profit Margin	11.15%	Recom	2.24	Target Price	133.76
Option/Short	Yes / Yes	LT Debt/Eq	0.42	EPS Q/Q	893.24%	Payout	-	Rel Volume	0.47	Prev Close	116.64
Sales Surprise	0.68%	EPS Surprise	13.65%	Sales Q/Q	1.98%	Earnings	Nov 04 BMO	Avg Volume	836.80K	Price	116.16
SMA20	1.37%	SMA50	-1.90%	SMA200	2.72%	Trades		Volume	92,305	Change	-0.41%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-15-24	Upgrade	Barclays	Equal Weight → Overweight	$125 → $140
Aug-28-24	Initiated	Wells Fargo	Equal Weight	$130
Jul-08-24	Initiated	Leerink Partners	Outperform	$125
Jun-03-24	Resumed	Jefferies	Hold	$115
Jan-16-24	Downgrade	UBS	Buy → Neutral	$105 → $125
Jan-04-24	Upgrade	Evercore ISI	In-line → Outperform	$88 → $125
Dec-19-23	Initiated	Wells Fargo	Equal Weight	$95
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Sep-28-23	Initiated	Bernstein	Outperform	$133
Jul-19-23	Initiated	Raymond James	Outperform	$145
May-23-23	Resumed	Goldman	Buy	$150

Show Previous Ratings

Dec-04-24 11:30AM	Why Is Revvity (RVTY) Down 8.7% Since Last Earnings Report? (Zacks)
Nov-26-24 06:35AM	Revvity price target lowered to $135 from $140 at Barclays (TipRanks)
Nov-20-24 08:00AM	Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK (Business Wire)
Nov-19-24 08:00AM	Scale Biosciences and Revvitys BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells (Business Wire)
08:00AM	Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference (Business Wire)
08:00AM	Loading…
Nov-18-24 08:00AM	Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation (Business Wire)
Nov-05-24 02:02AM	Revvity Inc (RVTY) Q3 2024 Earnings Call Highlights: Strong EPS and Cash Flow Amid Market Challenges (GuruFocus.com)
12:55AM	Q3 2024 Revvity Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-04-24 12:22PM	Analyst Report: Revvity, Inc. (Morningstar Research)
09:30AM	Here's What Key Metrics Tell Us About Revvity (RVTY) Q3 Earnings (Zacks)
07:10AM	Revvity (RVTY) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
06:09AM	Revvity: Q3 Earnings Snapshot (Associated Press Finance)
06:00AM	Revvity Announces Financial Results for the Third Quarter of 2024 (Business Wire)
Oct-28-24 10:01AM	Earnings Preview: Revvity (RVTY) Q3 Earnings Expected to Decline (Zacks)
Oct-24-24 04:05PM	Revvity Board Declares Quarterly Dividend (Business Wire)
09:00AM	Loading…
Oct-22-24 09:00AM	Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories (Business Wire)
08:00AM	Revvity Highlights its Strong Progress on Sustainability and Workplace Culture in 2024 Impact Report (Business Wire)
Oct-15-24 06:00AM	Revvity Ramps Up R&D Spending Since PerkinElmer Split (The Wall Street Journal)
Oct-09-24 05:18PM	Bionano Genomics Inc (BNGO) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com)
Oct-07-24 08:00AM	Revvity To Hold Earnings Call on Monday, November 4, 2024 (Business Wire)
Oct-02-24 08:00AM	Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene (Business Wire)
Aug-21-24 08:00AM	Revvity to Present at Upcoming Investor Conferences (Business Wire)
Aug-08-24 01:06AM	Decoding Revvity Inc (RVTY): A Strategic SWOT Insight (GuruFocus.com)
12:15AM	Bionano Genomics (BNGO) Q2 2024 Earnings Call Transcript (Motley Fool)
Jul-29-24 11:33PM	Q2 2024 Revvity Inc Earnings Call (Thomson Reuters StreetEvents) +9.07%
07:09PM	Analyst Report: Revvity, Inc. (Morningstar Research)
05:11PM	S&P 500 Gains and Losses Today: Onsemi Stock Jumps as Car Industry Drives Sales Beat (Investopedia)
12:19PM	Revvity (RVTY) Q2 Earnings Beat Estimates, Guidance Revised (Zacks)
10:48AM	Diagnostic Products Demand Boosts Profit and Sales at Revvity (Investopedia)
10:38AM	Life Science Firm Revvity Lifts Annual Profit Forecast On Strong Q2 Performance (Benzinga)
09:30AM	Loading…
09:30AM	Revvity (RVTY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
07:10AM	Revvity (RVTY) Tops Q2 Earnings Estimates (Zacks)
06:11AM	Revvity: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	Revvity Announces Financial Results for the Second Quarter of 2024 (Business Wire)
Jul-26-24 12:47PM	Revvity (RVTY) to Report Q2 Earnings: What's in the Cards? (Zacks)
Jul-25-24 04:15PM	Revvity Board Declares Quarterly Dividend (Business Wire)
Jul-22-24 10:01AM	Analysts Estimate Revvity (RVTY) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-19-24 12:10PM	Will Revvity (RVTY) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-09-24 08:00AM	Revvity To Hold Earnings Call on Monday, July 29, 2024 (Business Wire)
Jul-03-24 07:39AM	Reasons to Retain Revvity (RVTY) Stock in Your Portfolio Now (Zacks)
Jun-20-24 08:00AM	Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research (GlobeNewswire)
May-30-24 11:38AM	Reasons to Retain Revvity (RVTY) Stock in Your Portfolio Now (Zacks)
May-28-24 08:00AM	Revvity to Present at Goldman Sachs Global Healthcare Conference (Business Wire)
May-01-24 12:47PM	Revvity, Inc. (NYSE:RVTY) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-30-24 08:43AM	TD Cowen Adjusts Price Target on Revvity to $130 From $123 (MT Newswires)
07:08AM	Baird Adjusts Price Target on Revvity to $127 From $126 (MT Newswires)
06:06AM	Bernstein Adjusts Price Target on Revvity to $123 From $125, Keeps Outperform Rating (MT Newswires)
03:01AM	Revvity Inc (RVTY) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations with ... (GuruFocus.com)
Apr-29-24 10:36PM	Q1 2024 Revvity Inc Earnings Call (Thomson Reuters StreetEvents)
02:01PM	Analyst Report: Revvity, Inc. (Morningstar Research)
12:15PM	Revvity (RVTY) Q1 Earnings and Revenues Surpass Estimates (Zacks)
10:53AM	RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
10:11AM	Revvity Inc (RVTY) Q1 Earnings: Adjusted EPS Beats Estimates, Revenue Declines (GuruFocus.com)
09:51AM	Nephron Adjusts Revvity's Price Target to $124 From $120 (MT Newswires)
09:30AM	Revvity (RVTY) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
07:39AM	Revvity beats quarterly estimates on demand for diagnostic equipment (Reuters)
07:22AM	Revvity Q1 Adjusted Earnings, Revenue Down; Lowers 2024 Revenue Guidance (MT Newswires)
07:10AM	Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates (Zacks)
06:08AM	Revvity: Q1 Earnings Snapshot (Associated Press Finance)
06:00AM	Revvity Announces Financial Results for the First Quarter of 2024 (Business Wire)
Apr-25-24 04:15PM	Revvity Board Declares Quarterly Dividend (Business Wire)
12:50PM	Revvity's (RVTY) New Launch to Boost Tuberculosis Testing (Zacks)
08:00AM	Revvity to Present at BofA Securities 2024 Health Care Conference (Business Wire)
Apr-24-24 06:00AM	Revvity Unveils a New Era of Automated Tuberculosis Testing (Business Wire)
Apr-16-24 12:30PM	Revvity's (RVTY) Launch to Boost Pharma-Contract Partner Tie-Up (Zacks)
Apr-15-24 06:00AM	Revvity Signals Software's New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners (Business Wire)
Apr-10-24 10:03AM	Revvity (RVTY) Stock Jumps 4.1%: Will It Continue to Soar? (Zacks)
Apr-04-24 08:00AM	Revvity To Hold Earnings Call on Monday, April 29, 2024 (Business Wire)
Apr-02-24 06:00AM	Preliminary Injunction Granted to Enforce Revvity's Rights and Cloud Software Group's Obligations Related to Spotfire Software (Business Wire)
Apr-01-24 01:04PM	Three Reasons to Retain Revvity (RVTY) Stock in Your Portfolio (Zacks)
Mar-21-24 09:39AM	Revvity's (RVTY) New Launch to Boost Research Productivity (Zacks)
Mar-20-24 05:00PM	Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group (Business Wire)
Mar-18-24 11:34AM	Revvity's (RVTY) New Launch to Boost Newborn Sequencing Research (Zacks)
06:00AM	Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication (Business Wire)
Mar-06-24 06:30AM	Moderna Looks to Pare R&D Spending Even as It Pivots From Covid Vaccines (The Wall Street Journal)
Feb-29-24 05:04PM	Analyst Report: Revvity, Inc. (Morningstar Research)
Feb-28-24 12:03AM	Decoding Revvity Inc (RVTY): A Strategic SWOT Insight (GuruFocus.com)
Feb-21-24 08:00AM	Revvity to Present at Upcoming Investor Conferences (Business Wire)
Feb-14-24 04:55PM	Analyst Report: Revvity, Inc. (Morningstar Research)
Feb-12-24 04:05PM	Revvity Signals Software Unveils Signals Clinical Solution to Accelerate Critical Clinical Trial Insights and Data-Driven Decisions (Business Wire)
Feb-02-24 09:52AM	Revvity, Inc. (NYSE:RVTY) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-01-24 10:47PM	Q4 2023 Revvity Inc Earnings Call (Thomson Reuters StreetEvents)
01:46PM	Analyst Report: Revvity, Inc. (Morningstar Research)
10:41AM	Revvity (RVTY) Q4 Earnings Top, EPS View Above Expectation (Zacks)
09:30AM	Compared to Estimates, Revvity (RVTY) Q4 Earnings: A Look at Key Metrics (Zacks)
07:30AM	Revvity sees 2024 sales, profit above estimates (Reuters)
06:25AM	Revvity: Q4 Earnings Snapshot (Associated Press Finance)
06:22AM	Revvity Initiates 2024 Guidance - Quick Facts (RTT News)
06:00AM	Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023 (Business Wire)
Jan-25-24 04:15PM	Revvity Elects Sophie Vandebroek and Michael Klobuchar to its Board of Directors (Business Wire)
04:15PM	Revvity Board Declares Quarterly Dividend (Business Wire)
10:19AM	Revvity (RVTY) to Report Q4 Earnings: What's in the Cards? (Zacks)
Jan-09-24 08:00AM	Revvity to Hold Earnings Call on Thursday, February 1, 2024; Provides Update on Financial Performance (Business Wire)
Dec-19-23 08:00AM	Revvity to Present at J.P. Morgan Healthcare Conference (Business Wire)
Dec-01-23 07:47AM	Revvity (RVTY) Launches New Molecular Testing for Newborns (Zacks)
Nov-14-23 08:00AM	Revvity to Present at Annual Evercore ISI HealthCONx Conference (Business Wire)
Nov-06-23 09:02AM	Revvity, Inc. (NYSE:RVTY) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-31-23 08:54AM	Company News for Oct 31, 2023 (Zacks)
Oct-30-23 10:35PM	Q3 2023 Revvity Inc Earnings Call (Thomson Reuters StreetEvents) -16.13%
05:12PM	Why Revvity Stock Plunged Today (Motley Fool)

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. With a global network and localized agility, the company serves a diverse range of organizations from pharmaceutical and biotech to clinical labs, academia, and governments. It is headquartered in Waltham, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Singh Prahlad R.	Please See Remarks	Dec 02 '24	Option Exercise	81.29	18,365	1,492,891	108,560	Dec 03 04:05 PM
Singh Prahlad R.	Please See Remarks	Dec 02 '24	Sale	116.22	18,365	2,134,366	90,195	Dec 03 04:05 PM
Singh Prahlad R.	Officer	Dec 02 '24	Proposed Sale	115.79	18,365	2,126,483		Dec 02 10:55 AM
Vohra Tajinder S	Please See Remarks	Oct 09 '24	Sale	121.73	2,154	262,202	19,652	Oct 10 04:05 PM
Vohra Tajinder S	Officer	Oct 09 '24	Proposed Sale	121.73	2,154	262,199		Oct 09 04:21 PM
Vohra Tajinder S	Please See Remarks	Oct 08 '24	Sale	122.59	2,154	264,057	21,806	Oct 09 04:05 PM
Vohra Tajinder S	Please See Remarks	Oct 07 '24	Sale	122.09	2,153	262,853	23,960	Oct 09 04:05 PM
Vohra Tajinder S	Officer	Oct 08 '24	Proposed Sale	122.59	2,154	264,066		Oct 08 04:42 PM
Vohra Tajinder S	Officer	Oct 07 '24	Proposed Sale	122.09	2,153	262,855		Oct 07 04:10 PM
MICHAS ALEXIS P	Director	Aug 15 '24	Sale	118.62	850	100,827	7,770	Aug 16 04:05 PM
MICHAS ALEXIS P	Officer	Aug 15 '24	Proposed Sale	117.65	850	100,000		Aug 15 09:53 AM
Goldberg Joel S	Please See Remarks	Aug 07 '24	Sale	117.86	3,500	412,507	33,400	Aug 08 04:05 PM
Goldberg Joel S	Officer	Aug 07 '24	Proposed Sale	117.86	3,500	412,514		Aug 07 04:59 PM
Goldberg Joel S	Please See Remarks	Jun 07 '24	Sale	110.46	4,000	441,844	36,900	Jun 10 04:05 PM
MICHAS ALEXIS P	Director	Feb 29 '24	Sale	109.98	5,000	549,900	55,604	Mar 01 04:05 PM
Vohra Tajinder S	Please See Remarks	Feb 27 '24	Option Exercise	54.56	7,918	432,046	34,031	Feb 29 04:05 PM
Vohra Tajinder S	Please See Remarks	Feb 27 '24	Sale	105.39	7,918	834,441	26,113	Feb 29 04:05 PM
Goldberg Joel S	Please See Remarks	Feb 23 '24	Sale	105.13	835	87,784	40,900	Feb 26 04:05 PM
Singh Prahlad R.	Please See Remarks	Feb 23 '24	Sale	105.13	1,144	120,269	102,270	Feb 26 04:05 PM
Singh Prahlad R.	Please See Remarks	Feb 05 '24	Option Exercise	76.83	57,039	4,382,283	118,838	Feb 07 06:48 PM
Singh Prahlad R.	Please See Remarks	Feb 05 '24	Sale	104.28	21,217	2,212,480	92,801	Feb 07 06:48 PM
Victor Miriame	Please See Remarks	Feb 05 '24	Option Exercise	105.62	2,408	254,333	11,500	Feb 07 06:10 PM
Goldberg Joel S	Please See Remarks	Feb 05 '24	Option Exercise	64.18	28,907	1,855,347	53,500	Feb 07 05:50 PM
Goldberg Joel S	Please See Remarks	Feb 05 '24	Sale	104.28	15,475	1,613,696	38,025	Feb 07 05:50 PM
Tereau Daniel R	Please See Remarks	Feb 05 '24	Option Exercise	105.62	2,835	299,433	14,446	Feb 07 04:05 PM
Vohra Tajinder S	Please See Remarks	Feb 05 '24	Option Exercise	105.62	3,554	375,373	27,359	Feb 07 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RVTY

Revvity Inc

Upgrade your FINVIZ experience